(19)
(11) EP 4 127 209 A2

(12)

(88) Date of publication A3:
11.11.2021

(43) Date of publication:
08.02.2023 Bulletin 2023/06

(21) Application number: 21775064.5

(22) Date of filing: 24.03.2021
(51) International Patent Classification (IPC): 
C12Q 1/68(1980.01)
G01N 33/68(1980.01)
A61K 31/335(1974.07)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07D 403/12; C07D 471/04; C07D 409/12; C07D 487/04; C07D 239/48
(86) International application number:
PCT/US2021/023981
(87) International publication number:
WO 2021/195279 (30.09.2021 Gazette 2021/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 24.03.2020 US 202062994259 P
20.01.2021 US 202163139394 P

(71) Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Denver, CO 80203 (US)

(72) Inventors:
  • LABARBERA, Daniel V.
    Aurora, Colorado 80016 (US)
  • ABBOTT, Joshua M.
    Aurora, Colorado 80247 (US)
  • ZHOU, Qiong
    Aurora, Colorado 80016 (US)
  • ABRAHAM, Adedoyin D.
    Aurora, Colorado 80012 (US)
  • ESQUER, Hector
    Aurora, Colorado 80045 (US)
  • PRIGARO, Brett Joseph
    Broomfield, Colorado 80023 (US)

(74) Representative: FRKelly 
27 Clyde Road
Dublin D04 F838
Dublin D04 F838 (IE)

   


(54) SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER